Funding Cuts Jeopardize HIV Prevention Programs in South Africa
Published on: April 21, 2026, 6:42 p.m. | Source: Devdiscourse
U.S. funding cuts have adversely affected HIV prevention efforts in South Africa, jeopardizing the distribution of lenacapavir, a new HIV prevention drug. The cuts have dismantled essential programs, frustrating years of investment in research and health infrastructure, and leaving vulnerable populations without crucial services.
